- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05288699
Mobile App for Latinx Hazardous Drinkers With Clinical Anxiety
May 10, 2024 updated by: Michael J. Zvolensky, Ph.D.
Brief Personalized Feedback Intervention for Latinx Hazardous Drinkers: A Community-Based Intervention
The purpose of this study is to develop and examine a culturally adapted, brief, integrated, Spanish language mobile health application for the Android platform, optimized to deliver a personalized feedback intervention (PFI) designed to enhance knowledge regarding adverse anxiety-alcohol interrelations, increase motivation and intention to reduce hazardous drinking, and reduce positive attitudes and intention regarding anxiety-related alcohol use among Latinx hazardous drinkers with clinical anxiety.
Study Overview
Detailed Description
Investigators will develop a culturally adapted, brief, single-session, Spanish language, PFI delivered via a mobile health application for the Android platform through an iterative approach using expert input and focus groups.
Next, Latinx hazardous drinkers with clinical anxiety will assess program navigation and conduct usability testing.
Finally, Latinx hazardous drinkers with clinical anxiety will be recruited to complete the final prototype of the mobile health application in order to evaluate the feasibility, acceptability, and initial effects.
Initial screening will be conducted via telephone; baseline and post-treatment data will be collected in-person; and 1-week, 1-month, and 3-months follow-up data will be collected remotely.
Study Type
Interventional
Enrollment (Estimated)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Brooke Y Kauffman, Ph.D.
- Phone Number: 713-743-8056
- Email: bkauffma@central.uh.edu
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77204
- Recruiting
- RESTORE Laboratory: Research on Emotion, Substance Treatment Outcomes, and Racial Equity
-
Contact:
- Aniqua Salwa, B.A.
- Phone Number: 713-743-8056
- Email: asalwa@central.uh.edu
-
Principal Investigator:
- Michael J Zvolensky, Ph.D.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- 21 years of age or older
- self-identified as Latinx or Hispanic
- fluent in Spanish
- current hazardous drinking pattern
- current clinical anxiety
- able to provide written, informed consent
- owning an Android smartphone
Exclusion Criteria:
- currently involved in alcohol or other substance use program
- concurrent use of medication for anxiety or depression
- current engagement in psychotherapy for anxiety or depression
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Aliento
Participants complete the brief (~30 minute) intervention at baseline and will have access to intervention material for up to 3-months after the baseline appointment via the mobile health application.
|
Aliento is a culturally adapted, brief, personalized feedback intervention (PFI) to address alcohol misuse in the context of clinical anxiety delivered via a mobile application.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Alcohol Use Disorders Identification Test
Time Frame: Change from Baseline Pre PFI Completion to 3-months Post PFI Completion
|
The Alcohol Use Disorders Identification Test will be used to assess drinking quantity, craving, and related consequences to alcohol use.
The 10 items are rated with various Likert-type scales.
The measure produces a total score by adding all of the items of the measure with higher scores indicating greater problems with alcohol (possible range 0 to 40).
|
Change from Baseline Pre PFI Completion to 3-months Post PFI Completion
|
|
Overall Anxiety Severity and Impairment Scale
Time Frame: Change from Baseline Pre PFI Completion to 3-months Post PFI Completion
|
The 5-item Overall Anxiety Severity and Impairment Scale will be used to assess anxiety symptom severity and impairment.
Each of the items is rated on a Likert-type scale ranging from 0 to 4. Items are summed to produce a total score (possible range 0 to 20).
|
Change from Baseline Pre PFI Completion to 3-months Post PFI Completion
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Motivation to Reduce Alcohol Consumption Scale
Time Frame: Change from Baseline Pre PFI completion to Baseline Post PFI completion
|
The 1-item Motivation to Reduce Alcohol Consumption Scale will be used to measure current motivation/intention to reduce alcohol.
Participants will be asked to select the statement that best describes their motivation/intention to reduce drinking (e.g., "I really want to cut down on drinking alcohol and intend to in the next month").
Higher scores on this measure indicate greater motivation/intention to reduce alcohol consumption (possible range (0-7).
|
Change from Baseline Pre PFI completion to Baseline Post PFI completion
|
|
Modified Drinking Motives Questionnaire-Revised
Time Frame: Change from Baseline Pre PFI completion to Baseline Post PFI completion
|
The Modified Drinking Motives Questionnaire-Revised will be used to assess expectancies of drinking.
For the current study, the 4-item "Coping-anxiety" subscale will be used as a measure of expectancies of drinking to reduce/cope with anxiety.
The measure utilizes a 5-point Likert scale ranging from 1 (almost never/never) to 5 (almost always/always).
Scores are averaged with higher scores indicating greater expectancies of drinking to reduce/cope with anxiety (possible range 1 to 5).
|
Change from Baseline Pre PFI completion to Baseline Post PFI completion
|
|
Alcohol Attitudes Scale
Time Frame: Change from Baseline Pre PFI completion to Baseline Post PFI completion
|
The 7-item Alcohol Attitudes Scale will be utilized to measure maladaptive attitudes for drinking (e.g., "Drinking alcohol is good").
Items are rated on a Likert-type scale from 1 (strongly disagree) to 7 (strongly agree).
Scores will be averaged to create a composite score (possible range 1 to 7).
Higher scores indicate greater maladaptive attitudes for drinking.
|
Change from Baseline Pre PFI completion to Baseline Post PFI completion
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Michael J Zvolensky, University of Houston
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 4, 2022
Primary Completion (Estimated)
February 28, 2025
Study Completion (Estimated)
April 30, 2025
Study Registration Dates
First Submitted
March 10, 2022
First Submitted That Met QC Criteria
March 10, 2022
First Posted (Actual)
March 21, 2022
Study Record Updates
Last Update Posted (Actual)
May 14, 2024
Last Update Submitted That Met QC Criteria
May 10, 2024
Last Verified
May 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00003577
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
There is no plan to make individual participant data (IPD) available to other researchers.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anxiety
-
University of CalabriaNot yet recruitingAnxiety | Anxiety Disease | Anxiety and Distress | Public Speaking AnxietyItaly
-
Clinica Alemana de SantiagoUniversidad del DesarrolloRecruitingAnxiety | Induction of Anesthesia | Anxiety Preoperative | Technology Use | Child Anxiety | Anesthesia Care | Anxiety After SurgeryChile
-
Boston Medical CenterPatient-Centered Outcomes Research Institute; Boston University; Johns Hopkins... and other collaboratorsCompletedAnxiety Disorders | Anxiety | Anxiety Symptoms | Child Anxiety | Anxiety, Mild to Moderate | Pediatric Anxiety DisordersUnited States
-
AstraZenecaCompletedAnxiety Disorders | Anxiety | Anxiety Neuroses | Anxiety StatesUnited States
-
Abant Izzet Baysal UniversityRecruitingAnxiety | Parental AnxietyTurkey (Türkiye)
-
Florida State UniversityRecruitingAnxiety | Generalized Anxiety Disorder (GAD) | WorryingUnited States
-
Yale UniversityNational Institute of Mental Health (NIMH)CompletedGeneralized Anxiety Disorder | Anxiety Disorder of Childhood | Separation Anxiety Disorder of Childhood | Social Anxiety Disorder of ChildhoodUnited States
-
Institut National de la Santé Et de la Recherche...Active, not recruitingAnxiety Disorders | Anxiety | Anxiety and FearFrance
-
Prisma Health-UpstateCompletedAnxiety | Anxiety, Separation | Separation Anxiety | Anxiety Generalized
-
Ann & Robert H Lurie Children's Hospital of ChicagoUniversity of California, Los Angeles; University of CincinnatiActive, not recruitingAnxiety, Separation | Anxiety, Social | Anxiety, GeneralizedUnited States